Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Cognitive correlates of pragmatic language comprehension in adult traumatic brain injury: A systematic review and meta-analyses.

Rowley DA, Rogish M, Alexander T, Riggs KJ.

Brain Inj. 2017;31(12):1564-1574. doi: 10.1080/02699052.2017.1341645. Epub 2017 Sep 13. Review.

PMID:
28901780
2.

Counter-intuitive moral judgement following traumatic brain injury.

Rowley DA, Rogish M, Alexander T, Riggs KJ.

J Neuropsychol. 2018 Jun;12(2):200-215. doi: 10.1111/jnp.12117. Epub 2017 Feb 7.

PMID:
28168820
3.

Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, Karrison T, Burnette B, Idel C, Zhao M, Hoffman RM, Munn DH, Rowley DA, Schreiber H.

Cancer Immunol Res. 2013 Aug;1(2):123-33. doi: 10.1158/2326-6066.CIR-13-0058.

4.

Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.

Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, Kranz DM, Meredith SC, Rowley DA, Schreiber H.

Cancer Cell. 2013 Apr 15;23(4):516-26. doi: 10.1016/j.ccr.2013.03.018.

5.

A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth.

Wen FT, Thisted RA, Rowley DA, Schreiber H.

Oncoimmunology. 2012 Mar 1;1(2):172-178.

6.

Spleen cells from young but not old immunized mice eradicate large established cancers.

Schreiber K, Arina A, Engels B, Spiotto MT, Sidney J, Sette A, Karrison TG, Weichselbaum RR, Rowley DA, Schreiber H.

Clin Cancer Res. 2012 May 1;18(9):2526-33. doi: 10.1158/1078-0432.CCR-12-0127. Epub 2012 Mar 13.

7.

Densely granulated murine NK cells eradicate large solid tumors.

Liu RB, Engels B, Arina A, Schreiber K, Hyjek E, Schietinger A, Binder DC, Butz E, Krausz T, Rowley DA, Jabri B, Schreiber H.

Cancer Res. 2012 Apr 15;72(8):1964-74. doi: 10.1158/0008-5472.CAN-11-3208. Epub 2012 Feb 28.

8.

The road to the discovery of dendritic cells, a tribute to Ralph Steinman.

Rowley DA, Fitch FW.

Cell Immunol. 2012;273(2):95-8. doi: 10.1016/j.cellimm.2012.01.002. Epub 2012 Jan 28. Review.

PMID:
22326169
9.

Targeting stroma to treat cancers.

Engels B, Rowley DA, Schreiber H.

Semin Cancer Biol. 2012 Feb;22(1):41-9. doi: 10.1016/j.semcancer.2011.12.008. Epub 2011 Dec 24. Review.

10.

Targeting mutations predictably.

Schreiber H, Rowley JD, Rowley DA.

Blood. 2011 Jul 28;118(4):830-1. doi: 10.1182/blood-2011-06-357541. No abstract available.

PMID:
21799095
11.

Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.

Wu TH, Schreiber K, Arina A, Khodarev NN, Efimova EV, Rowley DA, Weichselbaum RR, Schreiber H.

Cancer Immun. 2011 Jun 30;11:2.

12.

Cancer. Awakening immunity.

Schreiber H, Rowley DA.

Science. 2010 Nov 5;330(6005):761-2. doi: 10.1126/science.1198345. No abstract available.

PMID:
21051618
13.

Prevention of renal allograft rejection without immune suppression: a model to revisit.

Rowley DA, Stuart FP, Fitch FW.

Clin Transplant. 2011 Jan-Feb;25(1):104-10. doi: 10.1111/j.1399-0012.2010.01314.x. Epub 2010 Aug 19.

PMID:
20731687
14.

IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Zhang B, Karrison T, Rowley DA, Schreiber H.

J Clin Invest. 2008 Apr;118(4):1398-404. doi: 10.1172/JCI33522.

15.

Equilibrium between host and cancer caused by effector T cells killing tumor stroma.

Zhang B, Zhang Y, Bowerman NA, Schietinger A, Fu YX, Kranz DM, Rowley DA, Schreiber H.

Cancer Res. 2008 Mar 1;68(5):1563-71. doi: 10.1158/0008-5472.CAN-07-5324.

16.

Cancer. Quo vadis, specificity?

Schreiber H, Rowley DA.

Science. 2008 Jan 11;319(5860):164-5. doi: 10.1126/science.1153713. No abstract available.

PMID:
18187644
17.

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.

Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX, Weichselbaum RR, Rowley DA, Kranz DM, Schreiber H.

J Exp Med. 2007 Jan 22;204(1):49-55. Epub 2007 Jan 8.

18.

Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments.

Schreiber K, Rowley DA, Riethm├╝ller G, Schreiber H.

Hematol Oncol Clin North Am. 2006 Jun;20(3):567-84. Review.

PMID:
16762725
19.

The role of stroma in immune recognition and destruction of well-established solid tumors.

Yu P, Rowley DA, Fu YX, Schreiber H.

Curr Opin Immunol. 2006 Apr;18(2):226-31. Epub 2006 Feb 3. Review.

PMID:
16459066
20.

Inflammation as a tumor promoter in cancer induction.

Philip M, Rowley DA, Schreiber H.

Semin Cancer Biol. 2004 Dec;14(6):433-9. Review.

PMID:
15489136
21.

Bystander elimination of antigen loss variants in established tumors.

Spiotto MT, Rowley DA, Schreiber H.

Nat Med. 2004 Mar;10(3):294-8. Epub 2004 Feb 22.

PMID:
14981514
22.
23.

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.

Spiotto MT, Yu P, Rowley DA, Nishimura MI, Meredith SC, Gajewski TF, Fu YX, Schreiber H.

Immunity. 2002 Dec;17(6):737-47.

24.

The pattern of gene expression in mouse Gr-1(+) myeloid progenitor cells.

Chen J, Rowley DA, Clark T, Lee S, Zhou G, Beck C, Rowley JD, Wang SM.

Genomics. 2001 Oct;77(3):149-62.

PMID:
11597140
25.

Immunological enhancement of primary tumor development and its prevention.

Schreiber H, Wu TH, Nachman J, Rowley DA.

Semin Cancer Biol. 2000 Oct;10(5):351-7. Review.

PMID:
11100883
26.

Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein.

Siegel CT, Schreiber K, Meredith SC, Beck-Engeser GB, Lancki DW, Lazarski CA, Fu YX, Rowley DA, Schreiber H.

J Exp Med. 2000 Jun 5;191(11):1945-56.

28.

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.

Seung LP, Rowley DA, Dubey P, Schreiber H.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6254-8.

30.
33.

Development of a fiber-optic sensor for trace metal detection in aqueous environments.

Ervin AM, Ewing KJ, Lamontagne RA, Aggarwal ID, Rowley DA.

Appl Opt. 1993 Aug 1;32(22):4287-90. doi: 10.1364/AO.32.004287.

PMID:
20830085
34.

Flow cytometric analysis of lymphocyte surface markers following a 1-Gy dose of gamma radiation.

Rowley DA, Kelley WA, Manders JH.

Aviat Space Environ Med. 1993 Jun;64(6):528-33.

PMID:
8338500
35.
36.

CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.

Koeppen HK, Singh S, Stauss HJ, Park BH, Rowley DA, Schreiber H.

Transplantation. 1993 Jun;55(6):1349-55.

PMID:
8100089
37.
38.

Quantitative measures of sympathetic skin response in diabetes: relation to sudomotor and neurological function.

Levy DM, Reid G, Rowley DA, Abraham RR.

J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):902-8.

39.

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.

Singh S, Ross SR, Acena M, Rowley DA, Schreiber H.

J Exp Med. 1992 Jan 1;175(1):139-46.

40.
41.

Cytokines and cancer: experimental systems.

Blankenstein T, Rowley DA, Schreiber H.

Curr Opin Immunol. 1991 Oct;3(5):694-8. Review.

PMID:
1755987
42.

Assessment of basal and stimulated sweating in diabetes using a direct-reading computerized sudorometer.

Levy DM, Reid G, Abraham RR, Rowley DA.

Diabet Med. 1991;8 Spec No:S78-81.

PMID:
1825965
43.
44.

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA.

Proc Natl Acad Sci U S A. 1990 Feb;87(4):1486-90.

45.
46.
47.

Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunity.

Mullen CA, Rowley DA, Schreiber H.

Cell Immunol. 1989 Mar;119(1):101-13.

PMID:
2522025
48.

A comparison of murine hepatic accessory cells and splenic dendritic cells.

Shah PD, Rowley DA, Latta SL, Magilavy DB.

Cell Immunol. 1989 Feb;118(2):394-405.

PMID:
2521309
49.

Unique tumor-specific antigens.

Schreiber H, Ward PL, Rowley DA, Stauss HJ.

Annu Rev Immunol. 1988;6:465-83. Review. No abstract available.

PMID:
3289573
50.

The immunological meaning of Thy-1-negative NK cells.

Rowley DA, Shah PD.

Immunol Today. 1986 Jul-Aug;7(7-8):196-8. doi: 10.1016/0167-5699(86)90101-5.

PMID:
25290396

Supplemental Content

Loading ...
Support Center